Specify compounds and methods for tumor cell reduction

• 收藏
• 分享

专利权人:

TUSK THERAPEUTICS LTD;CANCER RESEARCH TECHNOLOGY LIMITED

发明人:

GOUBIER, Anne,MERCHIERS, Pascal,SALIMU, Josephine,MOULDER, Kevin,QUEZADA, Sergio,PEGGS, Karl,ARCE VARGAS, Frederick,SOLOMON, Isabelle,GOYENECHEA CORZO, Beatriz

申请号：

PE2019001847

公开号：

PE20191812A1

申请日:

2018.03.13

申请国别(地区):

PE

年份:

2019

代理人:

摘要：

This is an anti-CD25 antibody, in which the alliance from interleucina-2 (IL-2) to CD25 is not restricted by this antibody； this anti-CD25 antibody competes with 7g7b6 and / or MA251 antibody in order to be added to CD25. He also mentioned a specific method of tumor cell reductionReferido un anticuerpo anti-CD25, en donde dicho anticuerpo no inhibe la union de la interleucina-2 (IL-2) a CD25； dicho anticuerpo anti-CD25 compite con el anticuerpo 7G7B6 y/o con el anticuerpo MA251 para unirse al CD25 humano. Tambien se refiere a un metodo para la reduccion celular especifica de tumor.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/